Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states

• প্রধান লেখক: Xinyao Qu (লেখক), Qiaohuan Deng (লেখক), Ying Li (লেখক), Peng Li (লেখক), Guangwen Liu (লেখক), Yanli Wang (লেখক), Zhengzhi Liu (লেখক), Shuang Yu (লেখক), Yang Cheng (লেখক), Yannan Zhou (লেখক), Jiahui Chen (লেখক), Qing Ren (লেখক), Zishu Yu (লেখক), Zhengjie Su (লেখক), Yicheng Zhao (লেখক), Haimiao Yang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

We conducted a phase I bioequivalence trial in healthy Chinese subjects in the fasting and postprandial states. The goal of this trial was to compare the pharmacokinetics and safety of the test preparation Cefaclor granule (Disha Pharmaceutical Group Co., Ltd.) and the reference preparation Cefaclor...